1	Experimental	Experimental	B-NP	JJ	O	3	NMOD	0
2	drug	drug	I-NP	NN	O	3	NMOD	0
3	therapy	therapy	I-NP	NN	O	0	ROOT	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	peritumoral	peritumoral	B-NP	JJ	O	7	NMOD	0
6	brain	brain	I-NP	NN	O	7	NMOD	0
7	edema	edema	I-NP	NN	O	4	PMOD	0
8	.	.	O	.	O	3	P	0

1	Four	Four	B-NP	CD	O	2	NMOD	0
2	drugs	drug	I-NP	NNS	O	9	SUB	0
3	with	with	B-PP	IN	O	2	NMOD	0
4	potential	potential	B-NP	JJ	O	8	NMOD	0
5	anti-peritumoral	anti-peritumoral	I-NP	JJ	O	8	NMOD	0
6	brain	brain	I-NP	NN	O	8	NMOD	0
7	edema	edema	I-NP	NN	O	8	NMOD	0
8	activity	activity	I-NP	NN	O	3	PMOD	18	activity
9	were	be	B-VP	VBD	O	0	ROOT	0
10	studied	study	I-VP	VBN	O	9	VC	0
11	using	use	B-VP	VBG	O	9	VMOD	0
12	the	the	B-NP	DT	O	17	NMOD	0
13	VX2	VX2	I-NP	NN	B-protein	17	NMOD	0
14	rabbit	rabbit	I-NP	NN	O	17	NMOD	0
15	brain	brain	I-NP	NN	O	17	NMOD	0
16	tumor	tumor	I-NP	NN	O	17	NMOD	0
17	model	model	I-NP	NN	O	11	OBJ	0
18	.	.	O	.	O	9	P	0

1	Meclofenamate	Meclofenamate	B-NP	NN	O	3	NMOD	0
2	and	and	I-NP	CC	O	3	NMOD	0
3	indomethacin	indomethacin	I-NP	NN	O	4	SUB	0
4	were	be	B-VP	VBD	O	0	ROOT	0
5	tested	test	I-VP	VBN	O	4	VC	0
6	in	in	B-PP	IN	O	5	VMOD	0
7	an	an	B-NP	DT	O	8	NMOD	0
8	attempt	attempt	I-NP	NN	O	6	PMOD	0
9	to	to	B-VP	TO	O	10	VMOD	0
10	confirm	confirm	I-VP	VB	O	8	NMOD	0
11	recent	recent	B-NP	JJ	O	12	NMOD	0
12	reports	report	I-NP	NNS	O	10	OBJ	0
13	of	of	B-PP	IN	O	12	NMOD	0
14	anti-edema	anti-edema	B-NP	JJ	O	15	NMOD	0
15	activity	activity	I-NP	NN	O	13	PMOD	18	activity
16	in	in	B-PP	IN	O	15	NMOD	0
17	non	non	B-NP	JJ	O	20	NMOD	0
18	steroidal	steroidal	I-NP	JJ	O	20	NMOD	0
19	anti-inflammatory	anti-inflammatory	I-NP	JJ	O	20	NMOD	0
20	drugs	drug	I-NP	NNS	O	16	PMOD	0
21	(	(	O	(	O	24	DEP	0
22	NSAID	NSAID	B-NP	NN	O	23	NMOD	0
23	's	's	B-NP	POS	O	24	DEP	0
24	)	)	O	)	O	20	NMOD	0
25	.	.	O	.	O	4	P	0

1	The	The	B-NP	DT	O	4	NMOD	0
2	'angiostatic	'angiostatic	I-NP	JJ	O	4	NMOD	0
3	'	'	I-NP	``	O	4	NMOD	0
4	steroids	steroid	I-NP	NNS	O	8	NMOD	0
5	17	17	I-NP	CD	O	6	NMOD	0
6	hydroxyprogesterone	hydroxyprogesterone	I-NP	NN	O	8	NMOD	0
7	and	and	I-NP	CC	O	8	NMOD	0
8	epicortisol	epicortisol	I-NP	NN	O	9	SUB	0
9	were	be	B-VP	VBD	O	0	ROOT	0
10	tested	test	I-VP	VBN	O	9	VC	0
11	because	because	B-PP	IN	O	10	VMOD	0
12	of	of	I-PP	IN	O	11	PMOD	0
13	their	their	B-NP	PRP$	O	14	NMOD	0
14	lack	lack	I-NP	NN	O	11	PMOD	0
15	of	of	B-PP	IN	O	14	NMOD	0
16	glucocorticoid	glucocorticoid	B-NP	NN	O	19	NMOD	0
17	and	and	I-NP	CC	O	19	NMOD	0
18	mineralocorticoid	mineralocorticoid	I-NP	NN	O	19	NMOD	0
19	effects	effect	I-NP	NNS	O	23	NMOD	0
20	and	and	O	CC	O	23	NMOD	0
21	their	their	B-NP	PRP$	O	23	NMOD	0
22	structural	structural	I-NP	JJ	O	23	NMOD	0
23	similarity	similarity	I-NP	NN	O	15	PMOD	0
24	to	to	B-PP	TO	O	23	NMOD	0
25	glucocorticoids	glucocorticoid	B-NP	NNS	O	24	PMOD	0
26	.	.	O	.	O	9	P	0

1	The	The	B-NP	DT	O	5	NMOD	0
2	protein	protein	I-NP	NN	O	5	NMOD	0
3	and	and	I-NP	CC	O	5	NMOD	0
4	water	water	I-NP	NN	O	5	NMOD	0
5	component	component	I-NP	NN	O	9	SUB	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	brain	brain	B-NP	NN	O	8	NMOD	0
8	edema	edema	I-NP	NN	O	6	PMOD	0
9	were	be	B-VP	VBD	O	0	ROOT	0
10	indirectly	indirectly	I-VP	RB	O	9	VMOD	0
11	quantitated	quantitate	I-VP	VBN	O	9	VC	0
12	.	.	O	.	O	9	P	0

1	None	None	B-NP	NN	O	6	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	the	the	B-NP	DT	O	5	NMOD	0
4	test	test	I-NP	NN	O	5	NMOD	0
5	drugs	drug	I-NP	NNS	O	2	PMOD	0
6	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	0
7	significant	significant	B-NP	JJ	O	8	AMOD	0
8	anti-edema	anti-edema	I-NP	JJ	O	9	NMOD	0
9	activity	activity	I-NP	NN	O	6	OBJ	18	activity
10	.	.	O	.	O	6	P	0

1	This	This	B-NP	DT	O	2	NMOD	0
2	work	work	I-NP	NN	O	3	SUB	0
3	does	do	B-VP	VBZ	O	0	ROOT	0
4	not	not	I-VP	RB	O	3	VMOD	0
5	confirm	confirm	I-VP	VB	O	3	VC	0
6	reports	report	B-NP	NNS	O	5	OBJ	0
7	that	that	B-SBAR	IN	O	6	NMOD	0
8	NSAID	NSAID	B-NP	NNP	O	9	NMOD	0
9	's	's	B-NP	POS	O	10	SUB	0
10	have	have	B-VP	VBP	O	7	SBAR	0
11	anti-edema	anti-edema	B-NP	JJ	O	12	NMOD	0
12	activity	activity	I-NP	NN	O	10	OBJ	18	activity
13	and	and	O	CC	O	10	VMOD	0
14	suggests	suggest	B-VP	VBZ	O	7	SBAR	0
15	that	that	B-SBAR	IN	O	14	VMOD	0
16	there	there	B-NP	EX	O	17	SUB	0
17	may	may	B-VP	MD	O	15	SBAR	0
18	be	be	I-VP	VB	O	17	VC	0
19	no	no	B-NP	DT	O	20	NMOD	0
20	correlation	correlation	I-NP	NN	O	18	PRD	0
21	between	between	B-PP	IN	O	20	NMOD	0
22	'angiostatic	'angiostatic	B-ADJP	JJ	O	26	NMOD	0
23	'	'	O	''	O	22	AMOD	0
24	and	and	O	CC	O	22	AMOD	0
25	anti-edema	anti-edema	B-NP	JJ	O	26	NMOD	0
26	activity	activity	I-NP	NN	O	21	PMOD	18	activity
27	in	in	B-PP	IN	O	26	NMOD	0
28	certain	certain	B-NP	JJ	O	30	NMOD	0
29	steroid	steroid	I-NP	NN	O	30	NMOD	0
30	compounds	compound	I-NP	NNS	O	27	PMOD	0
31	.	.	O	.	O	3	P	0

